About Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist FDA-approved for type 2 diabetes (Mounjaro) and weight management (Zepbound). It has shown superior weight loss outcomes compared to semaglutide in head-to-head trials. The dual-agonist mechanism provides enhanced metabolic benefits.
Tirzepatide & Type 2 Diabetes
Tirzepatide is FDA-approved as Mounjaro for type 2 diabetes. See the TruthTides evidence library for graded trial summaries and citations.
Content sourced from existing TruthTides clinical reference documentation. This is informational only. Consult a qualified physician.
Find a Tirzepatide prescriber in Dallas
Browse qualified physicians who prescribe Tirzepatide in the Dallas area, or search nationwide via telehealth.
Ask TruthSource AI
Ask anything about Tirzepatide for Type 2 Diabetes
Get a guardrailed, evidence-anchored answer from our clinical reference tool.
Open Reference ToolFind a Doctor
Search verified Tirzepatide prescribers nationwide
Filter by peptide, location, and telehealth availability.
Open Physician FinderAlso in Dallas
Tirzepatide for Type 2 Diabetes in Other Cities
This content is sourced from existing TruthTides clinical reference documentation. It does not constitute medical advice or treatment recommendations. Consult a qualified physician before starting any peptide therapy.